Journals

Vaccination-induced inflammatory accumulation of axillary lymph nodes detected by FDG-PET in a breast cancer patient

A B S T R A C T

Evaluation of axilla lymph node metastasis is very important in determining the treatment strategy for primary breast cancer. The imaging method 2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) provides reliable information about metastasis, however it has limitations. A 40-year-old female first noticed a mass in her left breast. Ultrasonography (US) showed an uncircumscribed mass measuring 1.5 cm beneath the nipple in her left breast, and swelling axilla lymph node as metastasis. Primary tumor and 4 axilla lymph nodes were detected as hot spot by FDG-PET. However, we got new information which she received influenza vaccination 4 days before she had undergone FDG-PET before determining the strategy with patient. To decide the plan of treatment, it was necessary to have the reliable imaging result, therefore, we performed the second FDG-PET 25 days after the influenza vaccination. We report a case showing false-positive of axillary lymph nodes by FDG-PET caused by influenza vaccination. Influenza vaccination before FDG-PET examination may cause axillary lymph node accumulations, especially within several days after vaccination.

K E Y W O R D S

Breast cancer, FDG-PET, axilla lymph node, influenza vaccination, false-positive

Abbreviations

FDG-PET: 2-fluoro-2-deoxy-D-glucose positron emission tomography, US: Ultrasonography, FNA: Fine needle aspiration cytology, IDC: Invasive ductal carcinoma, HER2: Human epidermal growth factor receptor 2, CEA: Carcinoembryonic antigen

Background

The evaluation of axilla lymph node metastasis is very important due to determine the strategy (primary operation or neoadjuvant chemotherapy) for primary breast cancer. Ultrasonography (US) is very convenience technology to evaluate the axilla lymph node and is widely used for early breast cancer in Japan. The fine needle aspiration cytology (FNA) and/or 2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) should be performed to confirm the diagnosis of axilla lymph node metastasis in breast cancer patients with suspicious of metastasis by US. The sentinel lymph node biopsy is standard procedure to determine the axilla lymph node metastasis at time of primary breast surgery in early breast cancer with nonsuspicious by FNA and FDG-PET.

FDG-PET is an imaging method that provides insight into the metabolism of glucose in tissues [1]. According to the meta-analysis, the specificity of FDG-PET in lymph node assessment is 94%, but their sensitivity is 63% [2]. As PET has an insufficient negative predictive value, it cannot rule out the existence of metastases. In contrast, FDG-PET is considered to have a high positive predictive value, if metastatic lymph nodes are detected by FDG-PET, therefore, it is often used to diagnose axilla-lymph node metastasis of breast cancer in clinical [3].

However, we report a case showing false-positive of axillary lymph nodes of FDG-PET caused by an influenza vaccination.

Case Report

A 40-year-old female first noticed a mass in her left breast. Mammography revealed a indistinctness mass in E area. US showed an uncircumscribed mass measuring 1.5×1.3×0.9 cm beneath the nipple in her left breast, and swelling axilla lymph node as metastasis. Primary breast tumor was diagnosed invasive ductal carcinoma (IDC) by US-guided core-needle biopsy. On immunohistochemically analysis, IDC cells were highly positive for both estrogen and progesterone receptors and negative for human epidermal growth factor receptor 2 (HER2). Axilla lymph node metastasis was confirmed according to FNA. Magnetic resonance imaging revealed a circumscribed small enhanced mass with a rapid-plateau pattern beneath the nipple in her left breast. Routine blood and chemical examinations as well as carcinoembryonic antigen (CEA) and carbohydrate antigen (CA15-3) were within normal ranges.

Primary tumor and 4 axilla lymph nodes were detected as hot spot by FDG-PET (figure1). In the cases diagnosed to have 4 or more axilla lymph node metastasis before the operation, we usually discuss neo adjuvant chemotherapy with the patients in practice. However, we got new information which she received influenza vaccination 4 days before she had undergone FDG-PET before determining the strategy with patient. To decide the plan of treatment, it was necessary to have the reliable imaging result, therefore, we performed the second FDG-PET 25 days after the influenza vaccination.

Science Repository

Figure 1:The second FDG-PET decrease (four to one) a number of positive lymph nodes by first.

The hot spots were decreased from 4 to 1 lymph node by second FDG-PET (figure 1). Consequently, we decided to precede the primary operation without neoadjuvant chemotherapy. The patient underwent a left modified radical mastectomy with axillary lymph node dissection and immediate reconstruction surgery with implant. In gross observation, the cut surface of mass was 1.2×1.2 cm. Histological examination revealed IDC with histological grade 2. On immunohistochemically analysis, IDC cells were highly positive for both estrogen and progesterone receptors and negative for HER2. The ki-67 labeling index was over 20%. 3 axilla lymph node metastases were detected. As adjuvant treatment, the patient undergoes TC (Docetaxel 75mg/m2+Cyclophosphamide 600mg/m2), and plan to undergo endocrine therapy after the chemotherapy.

Discussion

This is the first report that vaccination caused inflammatory accumulation of axillary lymph nodes by FDG-PET in breast cancer patient. We think this is false positive case of FDG-PET according to decreasing (four to one) a number of positive lymph nodes by first to second FDG-PET, and few metastatic lymph nodes diagnosed by histological examination in surgical specimens compared with first FDG-PET.

FDG-PET is useful in identifying the presence of high metabolic malignant cells used glucose. However, as with all modalities, FDG-PET has some limitations. FDG-PET is known to accumulate in infection and inflammation as well as in malignancy [4]. Immunization such as influenza vaccination may cause inflammation of lymph nodes, which is similar to axillary lymph node metastasis on FDG-PET [5-8]. In such false-positive cases, there is a possibility to be performed unnecessary surgical resection or other toxic treatment.

Shirone et al. reported that four fifth of patients (80%) who underwent vaccination less than 7 days previously showed abnormal accumulations in the axilla during an annual cancer-screening program [9]. In a previous report, abnormal axillary lymph node accumulation was found 10 days after influenza vaccination [10]. Taking account of these reports, influenza vaccination seems to be favorable to avoid two weeks before FDG-PET. In our case, the intervals between vaccination and first FDG-PET were 4 days.

In Japan, many people are performed the influenza vaccination due to official recommendation every year. The influzeza vacctination was also recommended before chemotherapy in breast cancer patient by the guideline of Japanese Breast Cancer Society [11]. The influenza vaccination was injected in the deltoid region or the laterally brachial region. A questionnaire about vaccination history including injection site can be helpful to evaluate whether increased FDG accumulation in lymph nodes was caused by vaccination.

Conclusion

We reported a case of false-positive findings on FDG-PET in diagnosis of breast cancer after vaccination. Influenza vaccination before FDG-PET examination may cause axillary lymph node accumulations, especially within several days after vaccination. Questionnaires about vaccination can be helpful to avoid false-positive findings on FDG-PET. We don’t recommend vaccination during two weeks before FDG-PET in early breast cancer patient.

Consent for Publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests

Author’s contributions

HK has operated this case and analyzed all date. AK, HK, MS, MH, AY, JI, NG, SO, MI, KS, and HI have been involved in drafting the manuscript and revising it critically for important intellectual content. All authors read and approved the final manuscript.

Article Info

Article Type
Case Report
Article History
Received 7 September, 2018
Accepted 20 September, 2018
Published 31 October, 2018
Copyright
© 2018 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
10.31487/j.SCR.2018.03.006

Author Info

Corresponding author
Ayumi Kataoka
Department of Breast oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan

Figures & Tables

Science Repository

Figure 1: The second FDG-PET decrease (four to one) a number of positive lymph nodes by first.

References

1. Jodlowska E, Czepczynski R, Wyszomirska A, Jarzabek G, Kedzia W, et al. (2016) Application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part I. Diagnosis of breast cancer prior to treatment. Contemporary oncology (Pozn) 20: 8-12. [Crossref]

 

2. Cooper KL, Harnan S, Meng Y, Ward SE, Fitzgerald P, et al. (2011) Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis. Eur J Surg Oncol 37: 187-198. [Crossref]

 

3. Koolen BB, Valdes Olmos RA, Elkhuizen PH, Vogel WV, Vrancken Peeters MJ, et al. (2012) Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy. Breast Cancer Res Treat 135: 231-240. [Crossref]

 

4. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK (2000)  Infection imaging using whole-body FDG-PET. Eur J Nucl Med 27: 822-832. [Crossref]

 

5. Williams G, Joyce RM, Parker JA (2006) False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization. Clin Nucl Med 31: 731-732. [Crossref]

 

6. Panagiotidis E, Exarhos D, Housianakou I, Bournazos A, Datseris I (2010) FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1). Eur Radiol 20: 1251-1253. [Crossref]

 

7. Thomassen A, Lerberg Nielsen A, Gerke O, Johansen A, Petersen H (2011) Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination. Eur J Nucl Med Mol Imaging 38: 894-898. [Crossref]

 

8. Burger IA, Husmann L, Hany TF, Schmid DT, Schaefer NG (2011) Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine. Clin Nucl Med 36: 848-853. [Crossref]

 

9. Shirone N, Shinkai T, Yamane T, Uto F, Yoshimura H, et al. (2012) Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination. Ann Nucl Med 26: 248-252. [Crossref]

 

10. Kim JE, Kim EK, Lee DH, Kim SW, Suh C, et al. (2011) False-positive hypermetabolic lesions on post-treatment PET-CT after influenza vaccination. Korean J Intern Med 26: 210-212. [Crossref]

 

11. Aihara T, Toyama T, Takahashi M, Yamamoto Y, Hara F, et al. (2016) The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer, 2015 edition. Breast Cancer 23: 329-342. [Crossref]